🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The incidence of second primary malignancies is reported for long-term maintenance lenalidomide with survival outcomes. Another one to look forward to today at ASH! 👏 👏 #ASH2019 #ASH19 #MyelomaUK #myeloma #changinglives

ouh.dk/default.asp?id… great to see the UK MRA Myeloma Risk Profile Perform in a rea-world population #ASH2019 @UKmyelomaforum Myeloma research at CTRU

UK-MRA Myeloma XIV (FiTNESs) has all approvals and is scheduled to open to recruitment in January 2020 @kennycairns #ASH19 #ASH2019

Coming up tomorrow...A great way to start the morning with Martin Kaiser presenting results from the NCRI Myeloma XI Trial! #MyelomaUK #myeloma #ASH19 #ASH2019

John Jones with a Myeloma XI trial poster at #ASH2019 poster session on Sunday #ASHAbstractAchievementAward 🏅 👇 👏 Leeds CTRU #MyelomaUK #myeloma

Want to hear about the sex differences in Multiple Myeloma Biology and Clinical Outcomes? Find out the results from the Myeloma XI Trial today between 6pm-8pm! ✍️🧐#ASH2019 #ASH19 #MyelomaUK

Last nights poster session with Matthew Jenner, Andrew Hall and Martin Kaiser with the optimum (MUK9) poster 👏👇 Great to see Leeds CTRU results out there! #ASH2019 #ASH19

The outcomes for males and females in the largest myeloma trial conducted so far, updating observations from MRC Myeloma IX -cebp.aacrjournals.org/content/20/8/1… #ASH2019 #FindOutMoreToday! 👇👇

Monday poster session III: Andrew Hall and Martin Kaiser showcasing results from the MUKSeven Trial 👏👇 #ASH2019 #AbstractAchievementAward #Myeloma #MyelomaUK

Monday poster session III: Sarah Bird presenting results from the Myeloma XI Trial 👏👇 #ASH2019 #AbstractAchievementAward #Myeloma #MyelomaUK

Fantastic news! The MUK12 trial has hit 50% recruitment 🥳👏Great work from all involved! 🥳👏#myeloma #MyelomaUK #ClinicalTrials #ResearchMatters

The Myeloma team have decked the halls!! 🎅 Myeloma research at CTRU #7DaysToGo #ChristmasSeason #FeelingFestive

Myeloma XII (ACCoRd), the largest randomised salvage transplant eligible study, has had its 400th patient registered! Congratulations to the trials team Gordon Cook @kennycairns @ctrumyeloma and thank you to all the participating hospitals for their continued support!

For those with an interest in high-risk #myeloma - our 'story behind the paper' on #MyelomaXI combined molecular risk profiling. Another great #UKMRA collaboration Graham jackson Myeloma research at CTRU Gordon Cook go.nature.com/2XNlyDV

We are delighted to announce that the FiTNEss (UK-MRA Myeloma XIV) study is now open to recruitment! Congratulations to the trials team and thank you for all the hard work in getting the trial open Gordon Cook Graham Jackson @kennycairns @ctrumyeloma Fantastic news! 🥳👏🥳👏

Brilliant to have been involved in so many practice changing trials! We love being part of this research community!

An article from University of Leeds about FiTNEss, a new clinical trial for patients with newly diagnosed multiple myeloma leeds.ac.uk/news/article/4…

#Publication #MyelomaXI+ - KRdc as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial doi.org/10.1371/journa… Graham jackson Charlotte Pawlyn Leeds CTRU

#ASH2021 has started today in Atlanta, Georgia. We have 6 abstracts being presented in the next few days. None of us have made the journey this year, but we will spend some time on our screens keeping up with the news.

Zoe Craig from Leeds CTRU presents her elegant and insightful re-analysis of the Myeloma XI trial soon at #ASH2021. Multi-state models are likely to be the trial endpoints of the future and this work demonstrates their ability to answer question relevant to patients.